Metropolitan Life Insurance Company (MetLife)’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,212	Closed	-$17.2K	–	1942
2024 Q1	$17.2K	Hold	1,212	–	–	﹤0.01%	1935
2023 Q4	$18.3K	Hold	1,212	–	–	﹤0.01%	1954
2023 Q3	$19.2K	Hold	1,212	–	–	﹤0.01%	1919
2023 Q2	$18.4K	Buy	+1,212	New	+$18.4K	﹤0.01%	1978